Videos
Metastatic Castration-Resistant Prostate Cancer
Gary D. Steinberg, MD, Bruce and Beth White Family Professor, professor of surgery, director, urologic oncology, University of Chicago Medicine, discusses the impact immunotherapy has had on bladder cancer.
Metastatic Castration-Resistant Prostate Cancer
HER2-Negative Metastatic Breast Cancer
HER2-Negative Metastatic Breast Cancer
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
Tucatinib: Chemo-Sparing Maintenance for HER2+ Metastatic Breast Cancer
2
Phase 3 Data Highlight Orca-T’s Clinical Benefits in Heme Malignancies
3
FDA Grants Regular Approval to Rucaparib for BRCA-Mutated mCRPC
4
PROs From ASCENT-04 Study of Sacituzumab Govitecan Plus Pembrolizumab in First-Line TNBC
5